Cargando…

Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II

Diagnosis of Crigler-Najjar syndrome type II (CNS-II) and Gilbert syndrome (GS) based on the serum bilirubin concentration is difficult, because this parameter can fluctuate under certain conditions. The aim of this study was to explore differences in UGT1A1 gene mutations, which cause both CNS and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Lei, Li, Man, Zhang, Liang, Teng, Xiaoying, Chen, Xiangmei, Zhou, Xingang, Ma, Zhiyuan, Qi, Liming, Wang, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690788/
https://www.ncbi.nlm.nih.gov/pubmed/29137095
http://dx.doi.org/10.1097/MD.0000000000008620
_version_ 1783279682829942784
author Sun, Lei
Li, Man
Zhang, Liang
Teng, Xiaoying
Chen, Xiangmei
Zhou, Xingang
Ma, Zhiyuan
Qi, Liming
Wang, Peng
author_facet Sun, Lei
Li, Man
Zhang, Liang
Teng, Xiaoying
Chen, Xiangmei
Zhou, Xingang
Ma, Zhiyuan
Qi, Liming
Wang, Peng
author_sort Sun, Lei
collection PubMed
description Diagnosis of Crigler-Najjar syndrome type II (CNS-II) and Gilbert syndrome (GS) based on the serum bilirubin concentration is difficult, because this parameter can fluctuate under certain conditions. The aim of this study was to explore differences in UGT1A1 gene mutations, which cause both CNS and GS, and pathological changes between CNS-II and GS. Ninety-five Chinese patients with hereditary unconjugated hyperbilirubinemia were enrolled in this study. Peripheral blood samples obtained from patients were used to evaluate bilirubin levels and for UGT1A1 gene testing. Percutaneous needle biopsy of the liver and staining of tissue samples with hematoxylin and eosin, Masson trichrome, reticulin, and Perl Prussian blue were performed for 59 patients. The Ishak scoring system was used to assess inflammatory activity and the extent of fibrosis. One hundred ninety-two UGT1A1 mutations at 6 sites were detected in the 95 patients; the most common mutation in GS was c.-3279T>G in the phenobarbital response enhancing motif of the UGT1A1 promoter, whereas the most common mutation in CNS-II was p.G71R. The frequency of heterozygous p.G71R mutations in CNS-II was significantly higher than that in GS (P = .001); however, the frequency of homozygous c.-3279T>G mutations in CNS-II was markedly lower than that in GS (P = .032). Among all patients with multiple mutations, the frequency of p.Y486D was significantly higher in CNS-II than in GS (P = .007). The frequency of compound c.-3279T>G, A(TA)(7)TAA, and p.G71R mutations in CNS-II was significantly higher than that in GS (P = .001). Among the 59 patients who underwent percutaneous needle biopsy, 20 had iron deposition in the liver. The frequency of hepatic iron deposition in CNS-II was significantly higher than that in GS (P = .002). The linked polymorphic mutations, A(TA)(7)TAA and c.-3279T>G in UGT1A1, were most strongly associated with GS, whereas mutations in the coding region, especially p.G71R and p.Y486D, were more strongly associated with CNS-II. Iron deposition was more common in liver biopsies from patients with CNS-II than in those with GS.
format Online
Article
Text
id pubmed-5690788
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-56907882017-11-28 Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II Sun, Lei Li, Man Zhang, Liang Teng, Xiaoying Chen, Xiangmei Zhou, Xingang Ma, Zhiyuan Qi, Liming Wang, Peng Medicine (Baltimore) 4500 Diagnosis of Crigler-Najjar syndrome type II (CNS-II) and Gilbert syndrome (GS) based on the serum bilirubin concentration is difficult, because this parameter can fluctuate under certain conditions. The aim of this study was to explore differences in UGT1A1 gene mutations, which cause both CNS and GS, and pathological changes between CNS-II and GS. Ninety-five Chinese patients with hereditary unconjugated hyperbilirubinemia were enrolled in this study. Peripheral blood samples obtained from patients were used to evaluate bilirubin levels and for UGT1A1 gene testing. Percutaneous needle biopsy of the liver and staining of tissue samples with hematoxylin and eosin, Masson trichrome, reticulin, and Perl Prussian blue were performed for 59 patients. The Ishak scoring system was used to assess inflammatory activity and the extent of fibrosis. One hundred ninety-two UGT1A1 mutations at 6 sites were detected in the 95 patients; the most common mutation in GS was c.-3279T>G in the phenobarbital response enhancing motif of the UGT1A1 promoter, whereas the most common mutation in CNS-II was p.G71R. The frequency of heterozygous p.G71R mutations in CNS-II was significantly higher than that in GS (P = .001); however, the frequency of homozygous c.-3279T>G mutations in CNS-II was markedly lower than that in GS (P = .032). Among all patients with multiple mutations, the frequency of p.Y486D was significantly higher in CNS-II than in GS (P = .007). The frequency of compound c.-3279T>G, A(TA)(7)TAA, and p.G71R mutations in CNS-II was significantly higher than that in GS (P = .001). Among the 59 patients who underwent percutaneous needle biopsy, 20 had iron deposition in the liver. The frequency of hepatic iron deposition in CNS-II was significantly higher than that in GS (P = .002). The linked polymorphic mutations, A(TA)(7)TAA and c.-3279T>G in UGT1A1, were most strongly associated with GS, whereas mutations in the coding region, especially p.G71R and p.Y486D, were more strongly associated with CNS-II. Iron deposition was more common in liver biopsies from patients with CNS-II than in those with GS. Wolters Kluwer Health 2017-11-10 /pmc/articles/PMC5690788/ /pubmed/29137095 http://dx.doi.org/10.1097/MD.0000000000008620 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 4500
Sun, Lei
Li, Man
Zhang, Liang
Teng, Xiaoying
Chen, Xiangmei
Zhou, Xingang
Ma, Zhiyuan
Qi, Liming
Wang, Peng
Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
title Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
title_full Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
title_fullStr Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
title_full_unstemmed Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
title_short Differences in UGT1A1 gene mutations and pathological liver changes between Chinese patients with Gilbert syndrome and Crigler-Najjar syndrome type II
title_sort differences in ugt1a1 gene mutations and pathological liver changes between chinese patients with gilbert syndrome and crigler-najjar syndrome type ii
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5690788/
https://www.ncbi.nlm.nih.gov/pubmed/29137095
http://dx.doi.org/10.1097/MD.0000000000008620
work_keys_str_mv AT sunlei differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT liman differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT zhangliang differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT tengxiaoying differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT chenxiangmei differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT zhouxingang differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT mazhiyuan differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT qiliming differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii
AT wangpeng differencesinugt1a1genemutationsandpathologicalliverchangesbetweenchinesepatientswithgilbertsyndromeandcriglernajjarsyndrometypeii